blog

An Interview with Valerie Bowling, Founder of the DPharm: Disruptive Innovations Conference

By BBK Worldwide on Tue, Sep 11, 2018 | 6 min read

We sat down with drug development industry researcher Valerie Bowling, a veteran conference director who covers the clinical trials market, to discuss her views on R&D trends and challenges and why she launched DPharm, a disruptive thinking conference for clinical trials (held this year in Boston, September 25-26).

Topics: Disruptive Innovation, Conferences, clinical research

When it Comes to Patient Data, Think First About the Patient

By BBK Worldwide on Thu, Aug 9, 2018 | 1 min read

 

Experts across the healthcare industry agree that patients should be able to easily access their medical data. While this sentiment is shared among key industry stakeholders, the ideas of “consumer centricity”, and how researchers specifically stand to benefit from delivering patient data, are popular talking points among experts in our industry.

Topics: clinical research, clinical trials, Pharma15, patient data

Agree or Disagree: Smaller Pharma Companies Are Leading the Way in Digital Health

By BBK Worldwide on Tue, Jul 24, 2018 | 1 min read

For digital health to be more widely implemented across the healthcare industry, smaller biopharma companies must be the first to demonstrate its efficacy. In this way, they must deliver specific real-world cases to prove to bigger pharma companies that digital health solutions are viable for the clinical R&D industry.

Topics: mHealth, clinical research, clinical trials, digital health

Taming the Study Data Explosion at DIA 2018

By BBK Worldwide on Wed, Jun 27, 2018 | 2 min read

While it’s hard to believe that today is the last day on the DIA 2018 exhibition floor, we are excited to continue collaborating, presenting, and interacting with our industry colleagues. Our poster session “Real World Data Meets Real World Evidence in Patient Recruitment and Engagement” made way for productive conversation that embodies the spirit of the DIA Annual Meeting. Today, we are back with a new poster session titled “Taming the Study Data Explosion: How to Leverage KPIs to Maximize Performance.”

Topics: clinical research, clinical trials, DIA 2018, KPIs

Clinical Trial Advertisers: Take Note of These Digital Trends

By BBK Worldwide on Tue, Jun 5, 2018 | 3 min read

The way people consume media is changing. With a projected 237.6 million estimated smartphone users by the end of 2018 in the United States alone (an increase of 13.3 million users from last year), the way people are accessing information is increasingly going mobile. Additionally, the Pew Research Center suggests that 64 percent of Americans between the ages 50 to 64 are using social media, preferring mediums like Facebook and YouTube. While the clinical trial industry is known to be slow in adopting newer technologies, the implications of these observed trends for patient recruitment speak for themselves. To get a closer look at the impact of digital media on clinical trial advertising, we spoke with our Director of Media and Research Sarah Mandracchia for her insights on some of the tactics and strategies that are shaping direct-to-consumer outreach in 2018.

Topics: advertising, clinical research, clinical trials, Digital Platforms

Agree or Disagree: Regulatory Bodies Need Social Media Training

By BBK Worldwide on Wed, Apr 25, 2018

If regulatory bodies are reviewing advertising and content for digital channels, like social media, should they receive education to understand how these channels work?

Check out the latest clip from our first Pharma15 Live! debate. Do you agree? Disagree? Leave a comment below.

Topics: Social Media, clinical research, Pharma15

BBK to Attend SCOPE 2018 in Orlando

By BBK Worldwide on Thu, Feb 8, 2018 | 2 min read

mobile-header.jpgBBK Worldwide is very excited to be participating in the 9th Annual SCOPE Summit for Clinical Ops Executives. Taking place February 12 – 15 in Orlando FL, SCOPE will offer three days of in-depth discussions addressing the operational, technological and data-related aspects of clinical trial planning and management, with 18 different conferences, 3 plenary keynote sessions and interactive breakout discussions.

Topics: Conferences, clinical research, life sciences

Insights from Dr. Elliot Rosenstein: Referring Physicians in Clinical Trials

By BBK Worldwide on Wed, Jan 31, 2018 | 4 min read

 

For our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.

Topics: Physician Referrals, clinical research, clinical trials, Most Viewed

Gone Are 60 Seconds

By Matt Kibby on Thu, Jan 4, 2018 | 4 min read

Picture this: a clammy Nicolas Cage sits hunched forward in the driver’s seat of a $5m hypercar, gripping the top of the steering wheel and staring at an undefined point just beyond the camera.

His grip on the wheel tightens and he punches the accelerator.

In a cacophony of protesting rubber and tire smoke, he’s Gone in 60 Seconds.

Sound familiar? I’m making a tenuous but spellbinding opening remark to get our blood flowing about advertising. Not just advertising in general but also, more specifically, patient recruitment advertising. 

Topics: advertising, clinical research, Most Viewed

eConsent: A Patient-Centric Perspective

By BBK on Thu, Nov 30, 2017 | 2 min read

When patients find themselves interacting with information about their health and well-being, it is the responsibility of healthcare professionals to ensure that these interactions are as meaningful and productive as they can be. In this regard, the informed consent process is among the most important facets of clinical research currently undergoing a digital transformation, and pharmaceutical companies must continue to adopt eConsent across the board.

Topics: clinical research, clinical trials, informed consent, digital health, Digital Platforms

 
Subscribe To Our Blog